Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Noribogaine is a G-protein biased κ-opioid receptor agonist.

Maillet EL, Milon N, Heghinian MD, Fishback J, Schürer SC, Garamszegi N, Mash DC.

Neuropharmacology. 2015 Dec;99:675-88. doi: 10.1016/j.neuropharm.2015.08.032. Epub 2015 Aug 21.

2.

Matrix metalloproteinase-1 contribution to sarcoma cell invasion.

Garamszegi N, Garamszegi SP, Scully SP.

J Cell Mol Med. 2012 Jun;16(6):1331-41. doi: 10.1111/j.1582-4934.2011.01402.x.

3.

Crosstalk Signalling Role in Modulation of Drugs Side Effects.

Garamszegi SP, Garamszegi N.

Curr Mol Pharmacol. 2011 May 10. [Epub ahead of print]

PMID:
21554210
4.

Matrix metalloproteinase 1: role in sarcoma biology.

Jawad MU, Garamszegi N, Garamszegi SP, Correa-Medina M, Diez JA, Wen R, Scully SP.

PLoS One. 2010 Dec 8;5(12):e14250. doi: 10.1371/journal.pone.0014250.

5.

Extracellular matrix-induced transforming growth factor-beta receptor signaling dynamics.

Garamszegi N, Garamszegi SP, Samavarchi-Tehrani P, Walford E, Schneiderbauer MM, Wrana JL, Scully SP.

Oncogene. 2010 Apr 22;29(16):2368-80. doi: 10.1038/onc.2009.514. Epub 2010 Jan 25.

PMID:
20101206
6.

Extracellular matrix-induced gene expression in human breast cancer cells.

Garamszegi N, Garamszegi SP, Shehadeh LA, Scully SP.

Mol Cancer Res. 2009 Mar;7(3):319-29. doi: 10.1158/1541-7786.MCR-08-0227. Epub 2009 Mar 10.

8.

Molecular mechanism of tenascin-C action on matrix metalloproteinase-1 invasive potential.

Galoian KA, Garamszegi N, Garamszegi SP, Scully SP.

Exp Biol Med (Maywood). 2007 Apr;232(4):515-22.

PMID:
17392487
9.
10.

siRNA mediated inhibition of MMP-1 reduces invasive potential of a human chondrosarcoma cell line.

Jiang X, Dutton CM, Qi WN, Block JA, Garamszegi N, Scully SP.

J Cell Physiol. 2005 Mar;202(3):723-30.

PMID:
15499569
11.

Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3.

Wilkes MC, Murphy SJ, Garamszegi N, Leof EB.

Mol Cell Biol. 2003 Dec;23(23):8878-89.

12.

Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway.

Penheiter SG, Mitchell H, Garamszegi N, Edens M, Doré JJ Jr, Leof EB.

Mol Cell Biol. 2002 Jul;22(13):4750-9.

13.

Transforming growth factor beta receptor signaling and endocytosis are linked through a COOH terminal activation motif in the type I receptor.

Garamszegi N, Doré JJ Jr, Penheiter SG, Edens M, Yao D, Leof EB.

Mol Biol Cell. 2001 Sep;12(9):2881-93.

14.
15.

The promoter region of the human PMCA1 gene mediates transcriptional downregulation by 1,25-dihydroxyvitamin D(3).

Glendenning P, Ratajczak T, Prince RL, Garamszegi N, Strehler EE.

Biochem Biophys Res Commun. 2000 Nov 2;277(3):722-8.

PMID:
11062020
16.
17.
18.

Application of a chimeric green fluorescent protein to study protein-protein interactions.

Garamszegi N, Garamszegi ZP, Rogers MS, DeMarco SJ, Strehler EE.

Biotechniques. 1997 Nov;23(5):864-6, 868-70, 872.

19.

Characterization of persistent artifacts resulting from RT-PCR of alternatively spliced mRNAs.

Zacharias DA, Garamszegi N, Strehler EE.

Biotechniques. 1994 Oct;17(4):652-5. No abstract available.

PMID:
7833018
21.
22.
23.

The detailed physical map of the temperate phage 16-3 of Rhizobium meliloti 41.

Dorgai L, Polner G, Jónás E, Garamszegi N, Ascher Z, Páy A, Dallmann G, Orosz L.

Mol Gen Genet. 1983;191(3):430-3.

PMID:
6314093

Supplemental Content

Loading ...
Support Center